June 29, 2021

A Declaration from Members of the World’s Biotechnology Sector On Global Access to COVID Vaccines & Treatments and the Role of Intellectual Property

We, the undersigned CEOs of global biotechnology companies and associations have a social responsibility to work with other stakeholders to ensure that COVID vaccines and treatments get to the patients in the world who most need them.
May 26, 2021

Enabling NGT products to contribute to sustainability: The role of Industrial Biotechnology

May 20, 2021

Decentralised clinical trials, the future of clinical research

The COVID-19 pandemic has been a catalyst for change which has led us to revisit the way we conduct clinical trials.
May 5, 2021

EuropaBio comments on the designation of official laboratories for animal and plant health and safe food and feedstuffs

EuropaBio comments on the draft delegated act on climate-related objectives under the Taxonomy Regulation.
May 5, 2021

EuropaBio comments on the new EU soil strategy

EuropaBio comments on the draft delegated act on climate-related objectives under the Taxonomy Regulation.
May 5, 2021

EUBA Statement on Revised draft Delegated Act on climate-related objectives

EuropaBio Statement – Vaccine production scale up: International collaboration remains the key.
April 16, 2021

Online Roundtable Report: An EU Vision For Life Science and Biotechnology for a Healthy and Sustainable EU

Webinar Report.
March 5, 2021

Webinar Report: Measuring the Economic Footprint of the Biotechnology Industry in Europe

Webinar Report.
March 1, 2021

Rare Disease Week 2021 – Interview with Dr. Ravi Rao, Head of Research & Development, Chief Medical Officer at Sobi

Read EuropaBios interview with Dr. Ravi Rao, Head of Research & Development, Chief Medical Officer at Sobi, on the occasion of Rare Disease Week 2021.
February 24, 2021

European Health Emergency Preparedness and Response Authority (HERA) Consultation – EuropaBio’s Feedback

On February 24th, EuropaBio submitted its feedback to the HERA Consultation.
February 4, 2021

EuropaBio draft response to the IIA on European Health Data Space

EuropaBio welcomes the European Commission’s plan to begin a discussion with stakeholders to develop the EHDS.
January 29, 2021

Building a European Health Union

EuropaBio welcomes the European Health Union plan. The EU has indeed a critical role to play in public health and better crisis preparedness to address serious cross-border health threats and improving crisis management capacity.
December 20, 2020

EuropaBio Comments on the Draft Delegated Act on Climate-Related Objectives under the Taxonomy Regulation

EuropaBio comments on the draft delegated act on climate-related objectives under the Taxonomy Regulation.
September 24, 2020

Genome editing FAQ

Genome editing is an advance in biological tools with the potential for a wide range of applications.
August 24, 2020

Genome-Edited Products and Projects: Resources and Examples

This is a non-exhaustive list of over 200 genome-editing or viral vector related products and research projects, drawn from various resources and covering healthcare, industrial and agricultural biotech
Become a member